Abstract
Prostate Cancer is the second most common malignancy worldwide in male. Serum total PSA (tPSA) testing has led to the identification of patients with indolent prostate cancer, and inevitably over-treatment has become a concern. Urine tumor (utDNA) provides new approach for non-invasive early detection of prostate cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
